Market Overview
The global clinical nutrition market size reached USD 55.8 Billion in 2024. This market is projected to grow to USD 104.6 Billion by 2033, reflecting a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2025 to 2033. Key factors propelling this growth include the increasing prevalence of chronic diseases, an aging population worldwide, rising awareness about nutrition’s importance in healthcare, and notable technological advancements in personalized and medical nutrition. Changing dietary patterns and lifestyle habits further stimulate the market’s expansion. Learn more at the Clinical Nutrition Market.
Study Assumption Years
Base Year: 2024
Historical Years: 2019-2024
Forecast Period: 2025-2033
Clinical Nutrition Market Key Takeaways
The global clinical nutrition market size was USD 55.8 Billion in 2024.
The market is forecasted to grow at a CAGR of 7.2% during 2025-2033.
Asia Pacific leads the global clinical nutrition market, driven by increasing chronic diseases.
Infant nutrition holds the largest market share among product segments.
The oral route of administration dominates, offering convenience and accessibility.
Pediatric end users account for the largest market share due to high nutritional needs.
Sample Request Link: https://www.imarcgroup.com/clinical-nutrition-market/requestsample
Market Growth Factors
Increasing Prevalence of Chronic Diseases and Aging Population
The clinical nutrition market is driven by the growing incidence of chronic diseases such as diabetes, cancer, osteoporosis, and cardiovascular disorders globally. Aging populations, particularly those aged 80 and above, are expected to triple by 2050 to reach 426 million according to WHO. Older adults face poor nutrient absorption and slowed metabolism, making clinical nutrition critical for managing long-term health issues. The rising prevalence of obesity and metabolic problems in elderly individuals further propels demand for nutritional therapies.
Rising Awareness About the Importance of Nutrition in Healthcare
Healthcare professionals and consumers increasingly recognize diet’s role in disease prevention and management. Clinical nutrition interventions involve evidence-based assessments, nutritional screening, and personalized nutrition solutions like functional foods and fortified ready-to-drink beverages. The RTD beverages market alone is projected to exceed US$ 402.0 Billion by 2032, indicating robust growth and adoption of these products for immune support, digestive health, and cognitive function.
Technological Advancements in Personalized Nutrition and Medical Therapy
Innovations in nutrigenomics, metabolomics, wearable technology, and digital health platforms enable tailored nutritional therapies. These technologies provide real-time feedback and remote monitoring, empowering individuals to manage health proactively. For example, FrieslandCampina Ingredients introduced Nutri WheyTM ProHeat, a heat-stable whey protein ingredient for medical nutrition using microparticulation technology, illustrating advances targeting patient-specific nutritional needs.
Market Segmentation
By Product:
Infant Nutrition: Constitutes the majority market share, focused on newborn dietary requirements including breast milk and infant formula providing essential nutrients and immune support.
Parental Nutrition: Included as a key product segment.
Enteral Nutrition: Categorized separately.
By Route of Administration:
Oral: Dominates the market; includes dietary supplements, functional foods, OTC pharmaceuticals, and oral nutritional supplements available in various convenient formats.
Enteral: Included as a segment.
Parenteral: Included as a segment.
By Application:
Cancer: Clinical nutrition addresses nutritional challenges from treatments and disease effects, supporting energy, protein, and nutrient intake.
Malnutrition: Tackles nutrient deficiencies caused by illness, aging, or socioeconomic factors through energy restoration and weight gain.
Metabolic Disorders: Nutrition therapy optimizes diet for conditions affecting energy metabolism and cardiovascular risk.
Gastrointestinal Disorders: Segment included.
Neurological Disorders: Segment included.
Others: Included as a category.
By End User:
Pediatric: Largest market share due to unique nutritional needs and supportive clinical nutrition for growth and disease prevention.
Adults: Included as a segment.
Geriatric: Included as a segment.
Regional Insights
Asia Pacific dominates the clinical nutrition market, holding the largest market share globally. Growth is fueled by rapid urbanization, changing diets, rising chronic disease burden, increasing income levels, and expanding healthcare access. The region’s aging population, especially in India and China, further drives demand. According to UNFPA, the population aged 80+ in India is projected to grow approximately 279% from 2022 to 2050, highlighting significant market opportunities.
Contact Out Analysts for Brochure Requests, Customization, and Inquiries Before Purchase:
https://www.imarcgroup.com/request?type=report&id=5995&flag=C
Recent Developments & News
On 16 February 2023, Nestlé Health Science and EraCal Therapeutics Ltd. announced a research collaboration to discover novel nutraceuticals for controlling food intake by combining Nestle’s nutraceutical resources with EraCal’s drug discovery platform.
On 3 May 2024, Danone completed the acquisition of Functional Formularies, a leading US whole foods tube feeding business, expanding its Medical Nutrition portfolio and enteral tube feeding ranges in the US.
Additionally, on 25 January 2023, Nutricia launched Fortimel® PlantBased Energy, a plant-based, ready-to-drink oral nutritional supplement formulated for malnourished or at-risk patients, suitable for vegan, vegetarian, or flexitarian diets and those with cow milk protein allergy.
Key Players
Abbott Laboratories
Ajinomoto Co., Inc.
Baxter International Inc.
Danone S.A
Fresenius Kabi Ltd
Kate Farms
Medifood
Nestlé Health Science
Perrigo Company plc
Reckitt
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization. https://www.imarcgroup.com/request?type=report&id=5995&flag=E
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
This release was published on openPR.
